[HTML][HTML] Dendrimer-2PMPA selectively blocks upregulated microglial GCPII activity and improves cognition in a mouse model of multiple sclerosis

KR Hollinger, A Sharma, C Tallon, L Lovell… - …, 2022 - ncbi.nlm.nih.gov
Cognitive impairment is a common aspect of multiple sclerosis (MS) for which there are no
treatments. Reduced brain N-acetylaspartylglutamate (NAAG) levels are linked to impaired …

[HTML][HTML] Dendrimer-2PMPA delays muscle function loss and denervation in a murine model of amyotrophic lateral sclerosis

C Tallon, A Sharma, Z Zhang, AG Thomas, J Ng… - …, 2022 - Springer
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease where
muscle weakness and neuromuscular junction (NMJ) denervation precede motor neuron …

[HTML][HTML] Systemic dendrimer-drug nanomedicines for long-term treatment of mild-moderate cerebral palsy in a rabbit model

Z Zhang, YA Lin, SY Kim, L Su, J Liu… - Journal of …, 2020 - Springer
Background Neuroinflammation mediated by microglia plays a central role in the
pathogenesis of perinatal/neonatal brain injury, including cerebral palsy (CP). Therapeutics …

[HTML][HTML] Preferential and increased uptake of hydroxyl-terminated PAMAM dendrimers by activated microglia in rabbit brain mixed glial culture

Y Alnasser, SP Kambhampati, E Nance, L Rajbhandari… - Molecules, 2018 - mdpi.com
Polyamidoamine (PAMAM) dendrimers are multifunctional nanoparticles with tunable
physicochemical features, making them promising candidates for targeted drug delivery in …

Dense hydroxyl polyethylene glycol dendrimer targets activated glia in multiple CNS disorders

A Sharma, R Sharma, Z Zhang, K Liaw… - Science …, 2020 - science.org
Poor transport of neuropharmaceutics through central nervous system (CNS) barriers limits
the development of effective treatments for CNS disorders. We present the facile synthesis of …

Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration

H Dai, RS Navath, B Balakrishnan, BR Guru… - …, 2010 - Future Medicine
Aim: Understanding the interactions between nanomaterials and disease processes is
crucial for designing effective therapeutic approaches. This article explores the unusual …

Dendrimer–tesaglitazar conjugate induces a phenotype shift of microglia and enhances β-amyloid phagocytosis

L DeRidder, A Sharma, K Liaw, R Sharma, J John… - Nanoscale, 2021 - pubs.rsc.org
Switching microglia from a disease exacerbating,'pro-inflammatory'state into a
neuroprotective,'anti-inflammatory'phenotype is a promising strategy for addressing multiple …

Phosphorus-Based Dendrimer ABP Treats Neuroinflammation by Promoting IL-10-Producing CD4+ T Cells

M Hayder, M Varilh, CO Turrin, A Saoudi… - …, 2015 - ACS Publications
Dendrimers are polyfunctional nano-objects of perfectly defined structure that can provide
innovative alternatives for the treatment of chronic inflammatory diseases, including multiple …

Effect of mannose targeting of hydroxyl PAMAM dendrimers on cellular and organ biodistribution in a neonatal brain injury model

A Sharma, JE Porterfield, E Smith, R Sharma… - Journal of controlled …, 2018 - Elsevier
Neurotherapeutics for the treatment of central nervous system (CNS) disorders must
overcome challenges relating to the blood-brain barrier (BBB), brain tissue penetration, and …

Dendritic polyglycerol sulfate inhibits microglial activation and reduces hippocampal CA1 dendritic spine morphology deficits

D Maysinger, D Gröger, A Lake, K Licha… - …, 2015 - ACS Publications
Hyperactivity of microglia and loss of functional circuitry is a common feature of many
neurological disorders including those induced or exacerbated by inflammation. Herein, we …